Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,738 | 172 | 51.3% |
| Consulting Fee | $7,000 | 2 | 41.1% |
| Travel and Lodging | $1,293 | 6 | 7.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $5,752 | 20 | $0 (2024) |
| Allergan, Inc. | $3,674 | 20 | $0 (2021) |
| Alimera Sciences, Inc. | $3,189 | 15 | $0 (2024) |
| Genentech USA, Inc. | $1,207 | 30 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $818.22 | 26 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $456.48 | 17 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $308.34 | 15 | $0 (2024) |
| Biogen, Inc. | $299.63 | 8 | $0 (2024) |
| Astellas Pharma US Inc | $284.04 | 8 | $0 (2024) |
| Dutch Ophthalmic, USA | $243.38 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,046 | 43 | Alimera Sciences, Inc. ($1,990) |
| 2023 | $1,735 | 37 | Alimera Sciences, Inc. ($442.67) |
| 2022 | $6,842 | 34 | ABBVIE INC. ($5,585) |
| 2021 | $425.42 | 17 | Allergan, Inc. ($159.35) |
| 2020 | $205.36 | 6 | Novartis Pharmaceuticals Corporation ($145.19) |
| 2019 | $561.06 | 13 | Novartis Pharmaceuticals Corporation ($184.15) |
| 2018 | $302.44 | 11 | Genentech USA, Inc. ($175.27) |
| 2017 | $3,913 | 19 | Allergan Inc. ($3,489) |
All Payment Transactions
180 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $10.08 | General |
| Category: Immunology and Ophthalmology | ||||||
| 12/17/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: EYE CARE | ||||||
| 12/06/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Ophthalmology | ||||||
| 11/22/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Ophthalmology | ||||||
| 11/21/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: EYE CARE | ||||||
| 11/07/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $34.02 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/07/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Ophthalmology | ||||||
| 11/05/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $34.18 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/30/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $34.44 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/01/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Ophthalmology | ||||||
| 09/26/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $264.51 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 09/23/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $31.69 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/16/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Ophthalmology | ||||||
| 09/11/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: Ophthalmology | ||||||
| 09/11/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Ophthalmology | ||||||
| 09/11/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Ophthalmology | ||||||
| 09/09/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $30.77 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/06/2024 | Genentech USA, Inc. | Susvimo (Drug) | Food and Beverage | In-kind items and services | $33.69 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/26/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $328.74 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 08/16/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Ophthalmology | ||||||
| 07/23/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/16/2024 | Astellas Pharma US Inc | Izervay (Drug) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: Ophthalmology | ||||||
| 07/15/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/11/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $33.47 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/03/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $36.52 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 6,942 | 101,923 | $21.3M | $6.2M |
| 2022 | 26 | 6,233 | 28,778 | $15.5M | $4.5M |
| 2021 | 23 | 5,397 | 20,467 | $13.7M | $4.2M |
| 2020 | 21 | 4,508 | 17,849 | $6.1M | $3.8M |
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 266 | 79,680 | $7.6M | $2.3M | 30.5% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 274 | 2,422 | $5.6M | $1.7M | 29.7% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 221 | 3,244 | $2.3M | $699,262 | 29.9% |
| 67028 | Injection of drug into eye | Office | 2023 | 859 | 3,394 | $1.1M | $325,893 | 28.3% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 102 | 1,270 | $1.0M | $234,577 | 22.7% |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | Office | 2023 | 102 | 985 | $738,750 | $169,469 | 22.9% |
| 92134 | Imaging of retina | Office | 2023 | 1,728 | 4,727 | $496,135 | $133,485 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 935 | 1,340 | $361,800 | $117,293 | 32.4% |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | Office | 2023 | 44 | 693 | $346,500 | $109,844 | 31.7% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 790 | 1,067 | $336,105 | $96,613 | 28.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 661 | 1,064 | $234,080 | $61,198 | 26.1% |
| J3490 | Unclassified drugs | Office | 2023 | 15 | 37 | $296,000 | $60,128 | 20.3% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 333 | 656 | $186,960 | $47,001 | 25.1% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 41 | 43 | $123,410 | $37,314 | 30.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 299 | 299 | $122,590 | $32,827 | 26.8% |
| 67113 | Complex repair of detached retina and drainage of eye fluid between lens and retina | Facility | 2023 | 25 | 29 | $96,715 | $27,836 | 28.8% |
| J3299 | Injection, triamcinolone acetonide (xipere), 1 mg | Office | 2023 | 12 | 720 | $82,980 | $27,185 | 32.8% |
| 67039 | Destruction of eye fluid (vitreous) between lens and retina using a laser | Facility | 2023 | 15 | 15 | $36,000 | $10,958 | 30.4% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 63 | 66 | $17,160 | $6,563 | 38.2% |
| 67210 | Destruction of growth of retina using a laser | Office | 2023 | 11 | 12 | $24,510 | $6,106 | 24.9% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 28 | 29 | $52,080 | $5,528 | 10.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 27 | 27 | $14,040 | $4,046 | 28.8% |
| 67228 | Destruction of leaking blood vessels of retina using laser | Office | 2023 | 11 | 13 | $13,500 | $3,174 | 23.5% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 31 | 31 | $11,625 | $3,087 | 26.6% |
| 0465T | Injection of medication into space above choroid membrane of eye | Office | 2023 | 12 | 18 | $4,590 | $1,562 | 34.0% |
About Dr. Sujit Itty, MD
Dr. Sujit Itty, MD is a Retina Specialist healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2009. The National Provider Identifier (NPI) number assigned to this provider is 1699902577.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sujit Itty, MD has received a total of $17,031 in payments from pharmaceutical and medical device companies, with $3,046 received in 2024. These payments were reported across 180 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($8,738).
As a Medicare-enrolled provider, Itty has provided services to 23,080 Medicare beneficiaries, totaling 169,017 services with total Medicare billing of $18.7M. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Practice Information
- Specialty Retina Specialist
- Other Specialties Ophthalmology
- Location Phoenix, AZ
- Active Since 06/17/2009
- Last Updated 01/26/2022
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1699902577
Products in Payments
- OZURDEX (Drug) $9,334
- YUTIQ (Drug) $2,237
- ILUVIEN (Drug) $892.36
- Vabysmo (Drug) $518.41
- EYLEA (Biological) $499.07
- Lucentis (Biological) $457.01
- EYLEA HD (Biological) $319.15
- XIPERE (Drug) $308.34
- BEOVU (Drug) $280.61
- EVA Ophthalmic Surgical System (Device) $125.00
- STELLARIS PC (Device) $121.09
- EVA, combined machine (Device) $118.38
- Syfovre (Drug) $113.17
- VABYSMO (Drug) $105.26
- Izervay (Drug) $104.15
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $85.34
- Humira (Biological) $77.25
- XIIDRA (Drug) $74.46
- Iluvien (Drug) $60.17
- Bromsite (Drug) $57.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Retina Specialist Doctors in Phoenix
Mr. Henry Kwong, Md, MD
Retina Specialist — Payments: $148,885
Rima Patel, Md, MD
Retina Specialist — Payments: $42,417
Dr. Neal Palejwala, Md, MD
Retina Specialist — Payments: $28,070
Dr. Suhail Alam, M.d, M.D
Retina Specialist — Payments: $14,080
Dr. Brian Horsman, Md, MD
Retina Specialist — Payments: $9,613
Kimberly Tran, M.d, M.D
Retina Specialist — Payments: $4,673